Novo Nordisk ‘strongly’ urges against pharma tariffs as comments flood in

Novo shares sink amid obesity drug competition - Business North Carolina

Novo Nordisk shares have lost more than half of their value in the 11 months since the Danish drugmaker said it’s going to spend $4.1 billion and create 1,000 jobs in a Johnston County expansion. The company’s troubles reflect stiffer competition for its obesity injection Wegovy — made in North Carolina — from rival Eli Lilly’s Zepbound treatment. Citing “recent market challenges” and the stock decline, Novo said earlier this month Lars Fruergaa…

Novo Nordisk ‘strongly’ urges against pharma tariffs as comments flood in

Novo Nordisk warned the US government not to impose pharma-specific tariffs, but instead to tax illegal importers of semaglutide, as comments for the Department of Commerce’s investigation into the sector start to roll in. ...

Novo Nordisk sank to the bottom: These shares took focusThe Danish stock market has gone into the weekend, and it is happening with a price drop in its luggage. The C25 index closed on Wednesday with a decrease of 1.04 percent. There has